In conclusion, our finding that inhibition of TDO resulted in failed resolution of RS and delays in repair of BCNU- and IR-induced DNA damage carries important implications for how aberrant KP signaling might influence disease progression in gliomas through increased genomic instability and tolerance of therapy-induced DNA damage. Here, TDO2 is linked to central nervous system cancer.